How Quickly Does Cosentyx Start Working?
Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, shows initial effects within 1-2 weeks for many patients. Skin clearance in psoriasis often improves by week 4, with 70-80% reaching PASI 75 (75% reduction in severity) by week 12 after weekly loading doses followed by monthly maintenance.[1]
Timeline for Psoriasis
- Week 1-2: Itching and redness decrease for most.
- Week 4: Visible skin improvement in about 50% of patients.
- Week 12: Peak response, with sustained benefits through year 5 in trials.[1][2]
Timeline for Psoriatic Arthritis and Ankylosing Spondylitis
Joint pain and stiffness ease within 2-4 weeks. ACR20 response (20% improvement) hits 50-60% by week 12-16; spinal symptoms in ankylosing spondylitis improve similarly by week 16.[1][3]
Factors Affecting Onset
Response varies by condition severity, body weight, prior treatments, and adherence. Heavier patients or those with long-standing disease may take longer. Full effects can require 3-6 months; non-responders by week 12 rarely improve later.[2]
What If It Doesn't Work Fast Enough?
Switching biologics is common if no improvement by week 12-16. Infections or injections sites can delay perceived effects—monitor for these.[3]
Cosentyx Dosing Schedule
Subcutaneous injection: 300mg weekly for 5 weeks (psoriasis), then every 4 weeks. Lower doses for arthritis (150-75mg). No oral version exists.[1]
[1]: Cosentyx Prescribing Information (Novartis)
[2]: Clinical Trials Data (NEJM, Lancet)
[3]: FDA Label and Patient Reviews (Drugs.com)